AKIN GUMP STRAUSS HAUER & FELD for ABBOTT LABORATORIES
A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 2nd Quarter - Report (this page) | Jul 20, 2022 | $60,000 | Replaced |
| 2nd Quarter - Amendment | Dec 19, 2022 | $60,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Strategic and policy advice related to health care issues, including COVID-19 legislation and regulations; monitor telehealth developments, appropriations, and other issues related to health care diagnostics; outreach and advocacy for future pandemic preparedness.
| Lobbyist | Covered position, as disclosed |
|---|---|
| LOUIS AGNELLO | — |
| JOSE BORJON | — |
| VIRGIL MILLER | — |
| MARIO RAMIREZ | — |
| ARSHI SIDDIQUI | — |
Taxation/Internal Revenue Code TAX
Issues related to international and corporate taxation in reconciliation legislation, including the Build Back Better Act (H.R.5376).
| Lobbyist | Covered position, as disclosed |
|---|---|
| ARSHI SIDDIQUI | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.